Masashi Ukai

Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function

Toshiyuki Takasu, Masashi Ukai, Shuichi Sato et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 310 citations

Medicine, Medicinal Chemistry, Pharmacology +6

In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats

Akiyoshi Ohtake, Masashi Ukai, Toshiki Hatanaka et al. · European Journal of Pharmacology · 2004 · 117 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A₂

Hideki Sakai, Tomoyuki Suzuki, Yûji Takahashi et al. · FEBS Letters · 2006 · 82 citations · Full text

Medicine, Molecular Biology, Oncology +13

Pharmacological Characterization of a New Antimuscarinic Agent, Solifenacin Succinate, in Comparison with Other Antimuscarinic Agents

Akiyoshi Ohtake, Chikashi Saitoh, Hironori Yuyama et al. · Biological and Pharmaceutical Bulletin · 2007 · 73 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats

Toshiki Hatanaka, Masashi Ukai, Mai Watanabe et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2012 · 46 citations

Medicine, Endocrinology, Pharmacology +11